Firas Rinawi
Haifa, HA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Histological activity predicts relapse in pediatric ulcerative colitis despite mucosal healing: a multicenter study from the pediatric IBD Porto group of ESPGHAN.
Journal: Journal of Crohn's & colitis
Published: June 08, 2026
Clinical and radiological outcomes of ustekinumab in pediatric perianal Crohn's disease: a multicenter retrospective study from the Pediatric IBD Porto Group of ESPGHAN.
Journal: Inflammatory bowel diseases
Published: March 10, 2026
Heterogeneous outcomes in pediatric potential celiac disease: A multicenter longitudinal study.
Journal: Journal of pediatric gastroenterology and nutrition
Published: February 23, 2026
Childhood-Onset Celiac Disease Autoimmunity and Risk of Depression and Anxiety across the Lifespan: A Longitudinal Analysis of a Large Real-World Cohort.
Journal: Digestion
Published: December 03, 2025
Safety and efficacy of weekly adalimumab 80 mg therapy in pediatric Crohn's disease.
Journal: Journal of pediatric gastroenterology and nutrition
Published: November 12, 2025
Upadacitinib Maintenance Therapy in Pediatric Ulcerative Colitis: 52-week Multicenter Study from the Porto Group of ESPGHAN.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: November 10, 2025
The Characteristics of Isolated Duodenal Bulb Coeliac Disease in Children: A Multicentre Retrospective Study.
Journal: Acta paediatrica (Oslo, Norway : 1992)
Published: May 11, 2025
Natural History of Cow's Milk Protein Allergy in Preterm Infants: Insights from a Retrospective Cohort Study.
Journal: International archives of allergy and immunology
Published: March 24, 2025
Long-Term Outcomes of Children Receiving Percutaneous Endoscopic Gastrostomy Feeding.
Journal: Medicina (Kaunas, Lithuania)
Published: January 07, 2025
Safety and efficacy of adalimumab 40 mg every 3 weeks in pediatric-onset Crohn's disease.
Journal: Journal of pediatric gastroenterology and nutrition
Published: November 25, 2024
Parameters associated with the development of autoimmune diseases in pediatric onset celiac disease.
Parameters associated with the development of autoimmune diseases in pediatric onset celiac disease.
Journal: European journal of pediatrics
Published: November 17, 2024
Upadacitinib for Induction of Remission in Paediatric Crohn's Disease: An International Multicentre Retrospective Study.
Journal: Alimentary pharmacology & therapeutics
Published: October 16, 2024
Last Updated: 09/26/2026